Study Protocol for "Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults".
David Sjöström, Olea Schau Rybäck, Emma Claesdotter-Knutsson, Petri Kajonius, Oskar Jensen Sondén, Per Carlbring, Johannes Björkstrand, Pouya Movahed Rad
PLoS One June 30, 2026 DOI: 10.1371/journal.pone.0352246 (opens in new tab) via PubMed
Summary
AI-generated from the abstractThis protocol outlines a planned study to examine the safety and therapeutic potential of psilocybin for treating anorexia nervosa in adolescents and young adults. It describes the rationale, design, and methods for a clinical trial that will assess whether psilocybin-assisted therapy can be safely administered to this population and whether it may help reduce eating disorder symptoms. The protocol specifies participant eligibility criteria, intervention procedures, outcome measures, and safety monitoring. No results are reported as the study has not yet been conducted.
Study at a glance
| Characteristics | Study protocol Peer reviewed |
|---|---|
| Population | Adolescents and young adults with anorexia nervosa |
| Intervention | Psilocybin |
| Key finding | Proposes to explore the safety and therapeutic potential of psilocybin for treating anorexia nervosa in adolescents and young adults. |
Abstract
Study Protocol for "Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults".